Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention.
Year: 2007
Type: article
Study design: Observational Study
Source: PubMed
Authors: O Bock, H Boerst, F E Thomasius, C Degner, M Stephan-Oelkers, S M Valentine, D Felsenberg
Institution: Charité – Universitätsmedizin Berlin
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2399824765
